Skip header and navigation

Narrow By

66 records – page 3 of 4.

Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2307
Available Online
View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Subjects (LCSH)
Kidneys--Diseases--Treatment
Specialty
Nephrology
Medications
Abstract
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2307
Less detail

Votre greffe de rein

https://libcat.nshealth.ca/en/permalink/chpams38227
Nova Scotia Health. Multi-Organ Transplant Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1127
Available Online
View Pamphlet
La greffe de rein est un traitement pour l’insuffisance rénale. L’insuffisance rénale est également connue sous le nom de maladie rénale chronique (MRC) et néphropathie chronique. Un rein en bonne santé provenant d’une personne (le donneur) est transplanté (greffé) chez une autre personne (le receveur). Le traitement est généralement très efficace. Ce guide explique ce à quoi vous attendre lors d'une greffe de rein. Les sujets abordés comprennent l'inscription sur la liste d'attente pour une gr…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Multi-Organ Transplant Program
Alternate Title
[Your kidney transplant]
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (68 p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Subjects (LCSH)
Kidneys--Transplantation
Specialty
Nephrology
Abstract
La greffe de rein est un traitement pour l’insuffisance rénale. L’insuffisance rénale est également connue sous le nom de maladie rénale chronique (MRC) et néphropathie chronique. Un rein en bonne santé provenant d’une personne (le donneur) est transplanté (greffé) chez une autre personne (le receveur). Le traitement est généralement très efficace. Ce guide explique ce à quoi vous attendre lors d'une greffe de rein. Les sujets abordés comprennent l'inscription sur la liste d'attente pour une greffe de rein, quoi faire dans l'attente de la greffe, à quoi vous attendre lorsqu'on vous appelle pour une greffe de rein, votre hospitalisation et votre rétablissement. Vous y trouverez aussi des renseignements sur la façon de rester en bonne santé à la maison, ainsi qu'une liste de ressources pour obtenir plus d'information.
This pamphlet is a French translation of the English pamphlet 0196, "Your Kidney Transplant". Having a kidney transplant is a treatment for kidney failure. Kidney failure is also known as Chronic Kidney Disease (CKD). A healthy kidney from one person (the donor) is placed (transplanted) into another person (the recipient). Treatment is usually very successful. This pamphlet explains what to expect when you have a kidney transplant. Topics include getting on the kidney transplant wait list, what to do while you wait for a kidney transplant, what to expect when you get called for a kidney, your hospital stay, and recovery. Information about staying healthy at home and a list of resources for more information is included.
Responsibility
Prepared by: Multi-Organ Transplant Program
Pamphlet Number
1127
Less detail

Parathyroidectomy and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams34702
Nova Scotia Health Authority. Nephrology/Dialysis Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0739
Available Online
View Pamphlet
Parathyroidectomy is a surgery that removes your parathyroid glands. Your parathyroid glands are in your neck (usually on the back of the thyroid gland). They help to control your blood calcium and phosporous levels. Hyperparathyroidism is when one or more of the parathyroid glands makes too much parathyroid hormone in your blood. If this happens, you will need a parathyroidectomy. This pamphlet explains what a parathyroidectomy is, the possible complications with this surgery, care after surge…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nephrology/Dialysis Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Parathyroidectomy
Kidney Diseases
Subjects (LCSH)
Parathyroidectomy
Kidneys--Diseases
Specialty
Nephrology
Surgery
Abstract
Parathyroidectomy is a surgery that removes your parathyroid glands. Your parathyroid glands are in your neck (usually on the back of the thyroid gland). They help to control your blood calcium and phosporous levels. Hyperparathyroidism is when one or more of the parathyroid glands makes too much parathyroid hormone in your blood. If this happens, you will need a parathyroidectomy. This pamphlet explains what a parathyroidectomy is, the possible complications with this surgery, care after surgery, how to take care of your incision, blood work, medications, and symptoms that need medical attention right away. A medication chart is included.
Responsibility
Prepared by: Nephrology/Dialysis Services
Pamphlet Number
0739
Less detail

Acute hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1151
Available Online
View Pamphlet
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Nephrology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Acute Kidney Injury
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Acute renal failure
Abstract
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Responsibility
Prepared by: Nephrology Services
Pamphlet Number
1151
Less detail

In-centre hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35162
Nova Scotia Health Authority. Central Zone. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1220
Available Online
View Pamphlet
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Renal Program
Alternate Title
In centre hemodialysis
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (24 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Kidneys--Diseases
Specialty
Nephrology
Abstract
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also included.
Notes
Previous titles: Renal (dialysis) patient handbook, Hemodialysis patient handbook
Responsibility
Prepared by: Renal Program, Central Zone
Pamphlet Number
1220
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

Tums (calcium carbonate) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1514
Available Online
View Pamphlet
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Specialty
Nephrology
Abstract
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Notes
Tums (calcium carbonate) and kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1514
Less detail

Over-the-counter medications and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1636
Available Online
View Pamphlet
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Nonprescription Drugs
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Drugs, Nonprescription
Chronic renal failure
Abstract
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why you should not take any herbal or natural health products is included.
Notes
Previous title: Over-the-counter medications & chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1636
Less detail

Let’s get cooking : kidney-friendly recipes

https://libcat.nshealth.ca/en/permalink/chpams35789
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1748
Available Online
View Pamphlet
Nutrition is an important way to manage your health, especially when it comes to chronic kidney disease. By eating or avoiding certain foods, you may help to keep your kidneys working for as long as possible. The most important nutrients that can affect your kidneys are protein, sodium, potassium, and phosphorus. This pamphlet gives information about these nutrients, as well as recipes to help people with chronic kidney disease manage their health.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (47 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Diet therapy
Abstract
Nutrition is an important way to manage your health, especially when it comes to chronic kidney disease. By eating or avoiding certain foods, you may help to keep your kidneys working for as long as possible. The most important nutrients that can affect your kidneys are protein, sodium, potassium, and phosphorus. This pamphlet gives information about these nutrients, as well as recipes to help people with chronic kidney disease manage their health.
Notes
Previous title: Let’s get cookin’ : kidney-friendly recipes
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
1748
Less detail

Taking your medications when you are sick after a kidney transplant

https://libcat.nshealth.ca/en/permalink/chpams35858
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1805
Available Online
View Pamphlet
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Medications
Subjects (LCSH)
Kidneys--Transplantation
Drugs
Specialty
Nephrology
Medications
Abstract
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot keep fluids down without vomiting is included.
Notes
Previous title: Taking your medications when you are ill after a kidney transplant : a guide for patients with a kidney transplant
Responsibility
Prepared by: Kidney Transplant Clinic, QEII
Pamphlet Number
1805
Less detail

Hepatitis B vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36604
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1425
Available Online
View Pamphlet
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Hepatitis B - prevention & control
Kidney Diseases
Subjects (LCSH)
Hepatitis B vaccine
Kidneys--Diseases
Specialty
Nephrology
Abstract
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get vaccinated. This pamphlet explains what the hepatitis B vaccine is, possible side effects, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1425
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1468
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can ca…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels of in the blood and weaker bones. One-Alpha® raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1470
Less detail

The Highly Sensitized Patient Program (HSP) for kidney transplant patients

https://libcat.nshealth.ca/en/permalink/chpams36746
Nova Scotia Health Authority. Multi-Organ Transplant Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2132
Available Online
View Pamphlet
A highly sensitized patient has a high amount of antibodies. This makes them more likely to reject an organ after transplant. This pamphlet explains how to know if you are highly sensitized, and how the Highly Sensitized Patient Program works.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Multi-Organ Transplant Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Subjects (LCSH)
Kidneys--Transplantation
Specialty
Nephrology
Abstract
A highly sensitized patient has a high amount of antibodies. This makes them more likely to reject an organ after transplant. This pamphlet explains how to know if you are highly sensitized, and how the Highly Sensitized Patient Program works.
Responsibility
Prepared by: Multi-Organ Transplant Program
Pamphlet Number
2132
Less detail

Living kidney donation

https://libcat.nshealth.ca/en/permalink/chpams38173
Nova Scotia Health Authority. MOTP Living Kidney Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2333
Available Online
View Pamphlet
There are never enough kidneys donated to do transplants for all the people who need them. Some people wait years for the right kidney to be donated. If you are interested in becoming a living kidney donor, this pamphlet will answer some common questions. Topics include: the benefits of a kidney transplant from a living donor, who can donate, deciding to donate, and how to get started if you want to donate a kidney. Information about the donation process, including evaluation, surgery, recovery…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. MOTP Living Kidney Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Organ transplantation
Kidney transplantation
Subjects (LCSH)
Donation of organs, tissues, etc.
Kidneys--Transplantation
Specialty
Nephrology
Abstract
There are never enough kidneys donated to do transplants for all the people who need them. Some people wait years for the right kidney to be donated. If you are interested in becoming a living kidney donor, this pamphlet will answer some common questions. Topics include: the benefits of a kidney transplant from a living donor, who can donate, deciding to donate, and how to get started if you want to donate a kidney. Information about the donation process, including evaluation, surgery, recovery, follow-up, and life after the donation, is included. Contact information for Atlantic Canada Living Kidney Donation Programs, as well as a list of resources, is given.
Responsibility
Prepared by: MOTP Living Kidney Program
Pamphlet Number
2333
Less detail

66 records – page 3 of 4.